Celebrating a Multi-Dimensional Success at Gsap!

At Gsap, we take pride in providing end-to-end support across quality, regulation, and clinical trial management (Gsap CRO), ensuring our clients achieve their goals efficiently and successfully.

Gsap CRO planned, executed, and managed the study end-to-end until the final CIR.

This month, we are thrilled to mark the completion of a long-term clinical study for Ivory graft, which developed Ivory Dentin Graft, for which we have participated for the past eight years.

Throughout this time, we managed the clinical trial, solved regulatory questions, and quality processes, leading to a significant milestone—CE approval for their Class III medical device!

This achievement is a testament to the multi-disciplinary impact Gsap brings to the industry. By integrating expertise across multiple domains, we accelerate innovation, reduce regulatory hurdles, and drive successful market entry for cutting-edge healthcare solutions.

This month, we are excited to announce the successful completion of the clinical study, which included the completion of 30 patients and obtained valuable insights.

Ivory Graft designed and developed the first porcine dentin xenograft. Ivory Dentin Graft™ is a dentin bone graft that retains the natural dentin form as well as the natural protein matrix and collagen, important for bone regeneration.

According to Amir, Ivory Graft CEO, “The Ivory Graft’s clinical results show superiority over porcine xenograft material, which is used in the dental industry today, due to the nature of dentin and its positive effect on bone growth.”

Partner with Gsap and experience the power of true end-to-end support. Our integrative approach—spanning clinical trial management, regulatory guidance, and quality assurance—ensures every milestone is met with precision and expertise. Let us help you accelerate innovation, overcome regulatory hurdles, and achieve outstanding execution for lasting impact in the healthcare industry.